Oct 1, 2021Targeted Oncology | Skin Toxicity in Cancer Treatment: A Critical Part of Cancer Supportive CareIn contrast to the innovations in cancer treatments that help drive improved survival, there are far fewer innovations targeting...
Sep 7, 2021OnQuality Pharmaceuticals Announces Completion of Part 1 of NOVA-II Trial - Top-line readout of clinical study results anticipated by the end of 2021 SEATTLE, Sept. 7, 2021 /PRNewswire/ -- OnQuality...
Jul 22, 2021The Bio Report | Targeting Cancer Drug Side Effects at Their SourceLink to Episode: http://thebioreport.com/2021/07/22/targeting-cancer-drug-side-effects-at-their-source/ While great strides have been...
Jul 12, 2021The Reorient! Podcast | Dr. Hong Tang: New Frontiers in US-China BiotechEpisode link: https://www.reorientpodcast.com/episodes/hong-tang Dr. Hong Tang is the Chief Medical Officer and co-founder of OnQuality...
Jul 12, 2021BioTech IQ | Targeting treatment related toxicities - Michael McCullar Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer...
Jul 1, 2021Health Professional Radio I OnQuality Pharmaceuticals – Phase 2 Cancer Supportive Care Therapy ForDr. Michael McCullar, CEO, and Dr. Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company...